Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Government Contract opportunity from Department Of Energy was posted on June 7, 2024. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

TECHNOLOGY/BUSINESS OPPORTUNITY High-density, high-channel count 3D connector for bioelectronic interfaces

Closed
IL-13932Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 334510
New
Federal
Ultrasound Diagnostic System, Hand Carried (USHC) - Prototype
Solicitation # W91CRB-RPP-USHC
The U.S. Army, through the Portfolio Acquisition Executive Maneuver Ground and Project Manager Maneuver Medical Devices, is soliciting prototype proposals for a hand-carried Ultrasound Diagnostic System (USHC). This effort is structured as a Direct Other Transaction Agreement under 10 U.S.C. 4022, meaning it is not a FAR-based contract. The government seeks a Commercial-Off-The-Shelf or Non-Developmental Item capable of supporting medical operations in austere Role of Care 3 environments, specifically for FAST exams, ultrasound-guided procedures, and ruling out deep vein thrombosis. Selected vendors must deliver two prototype units for operational and environmental testing in accordance with MIL-STD-810H. The system must be FDA cleared for human use, Trade Agreements Act compliant, and capable of operating on both CONUS and OCONUS power infrastructures. The estimated period of performance is twelve months, with prototype delivery expected 45 to 60 days after award. Evaluation is based on a comparative best-value methodology, prioritizing technical approach, performance compliance, reliability, schedule realism, and past performance over cost. Key requirements include MIL-STD-130N compliant IUID marking, NIST SP 800-171 cybersecurity compliance, and a minimum one-year warranty. Proposals must be submitted via DoD SAFE or secure email by November 6, 2026, and must adhere to strict page limits across four specific volumes. Notably, participants in this prototype agreement may be eligible for a noncompetitive follow-on production contract.
W6QK Acc-Apg

POSTED

about 18 hours ago

DEADLINE

in 16 days
NAICS: 334510
New
Federal
Automated Ultrasound-Based, Super Intelligence (SI)-Enabled Fracture Detection
Solicitation # BARDA-FY27-10192026
The Center for Biomedical Advanced Research and Development Authority (BARDA) has issued Sources Sought Notice BARDA-FY27-10192026 to identify innovative medical countermeasure technologies for the rapid triage of musculoskeletal injuries, such as fractures and soft tissue injuries of extremities. This request for information is intended for planning and market research purposes to assess commercially available or nearing-commercial technologies that utilize Super Intelligence (SI) and machine learning for automated ultrasound-based fracture detection. The goal is to find standalone, point-of-care devices that can operate in emergency departments, urgent care centers, and austere field settings without relying on traditional imaging infrastructure like X-ray or CT scans. The desired technology must feature automated volumetric capture, 3D-rotatable modeling, and SI-enabled image processing that outperforms human imaging experts and has undergone FDA 510k clearance processes. BARDA is interested in ruggedized, portable units with sufficient battery life for disaster response, interoperability with electronic health record systems, and minimal training requirements for non-specialist operators. Potential acquisition strategies being explored include direct purchases, leases, or vendor-managed inventory arrangements. Interested small businesses and other than small business concerns under NAICS code 334510 must submit their capabilities statements by 1:00 p.m. Eastern Time on November 18, 2026. Submissions must include separate Technical and Business Representation sections, each limited to 10 pages in 12-point Times New Roman font, and be emailed to Justin Moore and Richard Hall. Responses should detail the company's manufacturing capabilities within the United States, regulatory maturity, supply chain resilience, and cybersecurity standards for handling sensitive patient health information.
Barda - Aspr / Daappo / Barda Dcma

POSTED

1 day ago

DEADLINE

in 28 days

General Info

NAICS

334510 - Electromedical and Electrotherapeutic Apparatus Manufacturing

Place of Performance

Livermore, CA, USA

Set-Aside

NONE

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseClosed
Posted

special-notice

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Energy → Llns � DOE Contractor
Contacts2 people available
OfficeLivermore, CA, 94551, USA
Office AddressLivermore, CA, 94551, USA

Full Description

Show more
Opportunity: Lawrence Livermore National Laboratory (LLNL), operated by the Lawrence Livermore National Security (LLNS), LLC under contract no. DE-AC52-07NA27344 (Contract 44) with the U.S. Department of Energy (DOE), is offering the opportunity to enter into a collaboration to further develop and commercialize its high-density, high-channel count 3D connector technology for bioelectronic interfaces. Background: As bioelectronic interfaces trend toward smaller features and channel counts into the thousands, there is a need for a high-density connector to accommodate these signals and interface the passive bioelectronic interface to active electronics. Given that nearly the entire market for high-channel-count bioelectronic interfaces - and neural interfaces in particular - are in research and short-term clinical trials, this represents a major unmet need and untapped market segment. Current approaches depend on commercial connectors that have tens of contacts or permanent flip-chip or wire bonding techniques. These approaches, however, (a) dramatically increase the overall size of the device and are impractical to scale, (b) are time consuming to implement, and/or (c) are irreversible. Implantable bioelectronic interfaces are inherently single-use, and the custom active electronics are limited, so a nonpermanent connection strategy capable of handling high channel counts within a small volume is required. Description: LLNL researchers have designed and developed a novel high-density, high-channel count 3D connector that enables hundreds or thousands of nonpermanent connections within a compact footprint. The connector addresses limitations of currently used conventional approaches that were described previously, which have an artificial ceiling on the number of recording sites of modern devices of no more than 1000 channels. A small compression force is applied during the assembly of the high-density connector that allows for electrical connections to be made between two contact arrays. The novel design can include a compressible elastomeric layer and/or well-positioned bumps or ridges on backing plate that allow for even force distribution and improved electrical contact. Advantages/Benefits: Minimize total connector area and volume with fine pitch in two dimensions and the option to utilize the third dimension Reversible zero insertion force connection- it takes no (or negligible) force to mate two halves of a connector. A user simply brings the two halves of the connector together and it effortlessly snaps into functionally perfect alignment. Allow connection when one or both substrates are extremely flexible. Potential Applications: Currently available neural probes have integrated or permanently bonded custom electronics. The shortcoming of these probes is high device costs as the electronics are inherently single-use. While these probes are suitable for long-term clinical implantation in humans, they present a significant barrier to acute or sub-chronic clinical trials, fundamental research, early-stage commercial development, and cost-sensitive markets. LLNL's high-density, high channel connector could potentially fill thisd untapped market segment. Development Status: Current stage of technology development: TRL-2 LLNL has filed for patent protection on this invention. LLNL is seeking industry partners with a demonstrated ability to bring such inventions to the market. Moving critical technology beyond the Laboratory to the commercial world helps our licensees gain a competitive edge in the marketplace. All licensing activities are conducted under policies relating to the strict nondisclosure of company proprietary information. Please visit the IPO website at https://ipo.llnl.gov/resources for more information on working with LLNL and the industrial partnering and technology transfer process. Note: THIS IS NOT A PROCUREMENT. Companies interested in commercializing LLNL's high-density, high-channel count 3D connector technology for bioelectronic interfaces should provide an electronic OR written statement of interest, which includes the following: Company Name and address. The name, address, and telephone number of a point of contact. A description of corporate expertise and/or facilities relevant to commercializing this technology. Please provide a complete electronic OR written statement to ensure consideration of your interest in LLNL's high-density, high-channel count 3D connector technology for bioelectronic interfaces. The subject heading in an email response should include the Notice ID and/or the title of LLNL's Technology/Business Opportunity and directed to the Primary and Secondary Point of Contacts listed below. Written responses should be directed to: Lawrence Livermore National Laboratory Innovation and Partnerships Office P.O. Box 808, L-779 Livermore, CA 94551-0808 Attention: IL-13932

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS